Next Article in Journal
Time Trend of Upper Gastrointestinal Cancer Incidence in China from 1990 to 2019 and Analysis Using an Age–Period–Cohort Model
Previous Article in Journal
Neoadjuvant Chemo-Radiation Using IGRT in Patients with Locally Advanced Gastric Cancer
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Neuroendocrine Carcinomas of the Uterine Cervix, Endometrium, and Ovary Show Higher Tendencies for Bone, Brain, and Liver Organotrophic Metastases

Department of Pathology, Chungnam National University School of Medicine, Daejeon 35015, Korea
Curr. Oncol. 2022, 29(10), 7461-7469; https://doi.org/10.3390/curroncol29100587
Submission received: 3 September 2022 / Revised: 2 October 2022 / Accepted: 4 October 2022 / Published: 6 October 2022
(This article belongs to the Section Gynecologic Oncology)

Abstract

Neuroendocrine carcinoma (NEC) of the female genital tract is a rare and aggressive subtype of cancer that is still poorly understood. Several recent studies reported that pulmonary and gastroenteropancreatic neuroendocrine neoplasms show significantly different patterns of metastasis compared to non-NECs of the same primary sites. The aim of this study was to evaluate the metastatic patterns of gynecologic NECs and to compare the metastatic patterns of NECs and non-NECs of the same primary sites. We retrieved and analyzed cervical, endometrial, and ovarian NEC cases from the Surveillance, Epidemiology, and End Results (SEER) database. To validate the results, we also retrieved and analyzed cervical NEC cases from an institutional database. Uterine cervical NEC was the most common NEC. The overall metastatic rate was significantly higher in the NEC group than in the non-NEC group for all three primary sites. All cervical, endometrial, and ovarian NECs showed a higher tendency for bone, brain, and liver organotrophic metastasis than non-NECs of the same primary sites. We demonstrated that gynecologic NECs show significantly different metastatic patterns compared to non-NECs of the same primary sites. These findings might help clinicians to better manage patients with gynecologic NECs.
Keywords: neuroendocrine; cervical cancer; endometrial cancer; ovarian cancer; metastasis neuroendocrine; cervical cancer; endometrial cancer; ovarian cancer; metastasis

Share and Cite

MDPI and ACS Style

Park, H.K. Neuroendocrine Carcinomas of the Uterine Cervix, Endometrium, and Ovary Show Higher Tendencies for Bone, Brain, and Liver Organotrophic Metastases. Curr. Oncol. 2022, 29, 7461-7469. https://doi.org/10.3390/curroncol29100587

AMA Style

Park HK. Neuroendocrine Carcinomas of the Uterine Cervix, Endometrium, and Ovary Show Higher Tendencies for Bone, Brain, and Liver Organotrophic Metastases. Current Oncology. 2022; 29(10):7461-7469. https://doi.org/10.3390/curroncol29100587

Chicago/Turabian Style

Park, Hyung Kyu. 2022. "Neuroendocrine Carcinomas of the Uterine Cervix, Endometrium, and Ovary Show Higher Tendencies for Bone, Brain, and Liver Organotrophic Metastases" Current Oncology 29, no. 10: 7461-7469. https://doi.org/10.3390/curroncol29100587

APA Style

Park, H. K. (2022). Neuroendocrine Carcinomas of the Uterine Cervix, Endometrium, and Ovary Show Higher Tendencies for Bone, Brain, and Liver Organotrophic Metastases. Current Oncology, 29(10), 7461-7469. https://doi.org/10.3390/curroncol29100587

Article Metrics

Back to TopTop